Patent assignee · SE · COMPANY

Active Biotech AB

44Patents
23Active
44Granted
48Portfolio score

Filing activity: Jun 7, 1995 → Sep 7, 2022 · 10 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7226595B2 Modified Chimeric superantigens and their use Chemistry; Metallurgy 58 Expired
US7763253B2 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent Chemistry; Metallurgy 57 Expired
US6395750B1 Drugs for the treatment of malignant tumors Chemistry; Metallurgy 56 Expired
US7125554B2 Engineered superantigen for human therapy Electricity 54 Expired
US6962694B1 Cytolysis of target cells by superantigen conjugates inducing T-cell activation Chemistry; Metallurgy 54 Expired
US7615225B2 Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen Electricity 50 Active
US6077851A Quinoline derivatives Human Necessities 44 Expired
US6593343B2 Quinoline derivatives Human Necessities 37 Expired
US6121287A Quinoline derivatives Human Necessities 35 Expired
US6875869B2 Process for the manufacture of quinoline derivatives Chemistry; Metallurgy 35 Expired
US6133285A Quinoline derivatives Human Necessities 33 Expired
US7560557B2 Process for the manufacture of quinoline derivatives Chemistry; Metallurgy 29 Active
US7589208B2 Compositions containing quinoline compounds Human Necessities 27 Active
US6605616B1 Quinoline derivatives Human Necessities 26 Expired
US8314124B2 Crystalline salts of quinoline compounds and methods for preparing them Chemistry; Metallurgy 9 Active
US7074831B2 Compounds, methods for their preparation and use thereof Chemistry; Metallurgy 7 Expired
US7226601B1 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate Chemistry; Metallurgy 6 Expired
US6642249B2 Immunomodulating compounds Chemistry; Metallurgy 3 Expired
US8545885B2 Stable laquinimod preparations Emerging Cross-Sectional Technologies 2 Active
US7189816B1 Compounds Emerging Cross-Sectional Technologies 2 Expired
US11478465B2 Compounds for treatment of eye diseases associated with excessive vascularisation Chemistry; Metallurgy 2 Active
US6518312B2 Immune enhancement Human Necessities 2 Expired
US9956212B2 Quinoline carboxamides for use in the treatment of multiple myeloma Chemistry; Metallurgy 1 Active
US7425623B2 Antibody with specificity for colon cancer Chemistry; Metallurgy 1 Expired
US7291612B2 Immunomodulatory compounds Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.